Germ cells are physically coupled to somatic support cells of the gonad during differentiation, but this coupling must be disrupted when they are mature, freeing them to participate in fertilization. In mammalian females, coupling occurs via specialized filopodia that project from the ovarian follicular granulosa cells to the oocyte. Here, we show that signaling through the epidermal growth factor receptor (EGFR) in the granulosa, which becomes activated at ovulation, uncouples the germ and somatic cells by triggering a massive and temporally synchronized retraction of the filopodia. Although EGFR signaling triggers meiotic maturation of the oocyte, filopodial retraction is independent of the germ cell state, being regulated solely within the somatic compartment, where it requires ERK-dependent calpain-mediated loss of filopodia-oocyte adhesion followed by Arp2/3-mediated filopodial shortening. By uncovering the mechanism regulating germ-soma uncoupling at ovulation, our results open a path to improving oocyte quality in human and animal reproduction.
Cell contact and adhesion play indispensable roles in the development of multicellular organisms and maintenance of tissue homeostasis1, and the loss of intercellular adhesion is frequently associated with pathological events including metastatic migration of tumor cells2. Germ cells, however, present a rare and striking exception to this general principle. Like most other cell types, their differentiation requires intimate contact and interaction with supporting somatic cells of the gonad, which provide essential molecular nutrients and regulatory signals3,4,5,6,7,8,9. In contrast to most other cell types, however, once germ cells are mature, their function requires loss of contact with the somatic support cells, freeing them to participate in fertilization. The timely loss of germ-soma contact is linked to improved gamete and embryo quality including in humans10,11,12, indicating that mechanisms have evolved to ensure that germ-somatic contact is not disrupted precociously when the germ cells are immature, yet is disrupted efficiently in mature gametes so that they may interact to generate a new organism. Despite the functional imperative of breaking germ-soma contact prior to fertilization, little is known in any species of the mechanisms that underpin this critical process.
The mammalian follicle represents an ideal model system to address this gap in knowledge. First, its architecture is simple and well defined. The centrally located oocyte is surrounded by concentric layers of somatic granulosa cells, a basement membrane, and theca cells13. Interposed between the growing oocyte and the granulosa cells is a thick extracellular matrix, termed the zona pellucida14. Overcoming this physical impediment, germ-soma contact and communication is mediated by specialized actin-rich filopodia, termed transzonal projections (TZPs), that extend from the granulosa cells through the zona pellucida to the oocyte13,15,16,17,18. Thus, the physical structures mediating germ-soma adhesion are clearly defined and can be easily visualized. Second, adhesion is broken at a defined time in the reproductive cycle. Luteinizing hormone (LH) released by the anterior pituitary at the time of ovulation binds to its receptor (LHCGR; luteinizing hormone/choriogonadotropin receptor) in the mural granulosa cells adjacent to the follicular wall, triggering among other events the release of epidermal growth factor (EGF)-like peptides that activate the EGF receptor (EGFR) located on both the mural granulosa and the cumulus granulosa adjacent to the oocyte (Fig. 1)19,20,21. Although the relative roles of direct LHCGR and EGFR-mediated signaling remain to be fully established, this signaling cascade triggers the final phase of oocyte differentiation, termed meiotic maturation. Germ-soma contact is irreversibly broken at this time, as the TZPs disappear and the cumulus granulosa cells become displaced away from the oocyte. Third, conditions have been developed for culturing complexes comprising the oocyte and the surrounding somatic follicular cells. These conditions maintain the natural 3-dimensional architectural relationship between the two cell types and support both growth and maturation, thus enabling experimental analysis of the underlying mechanisms in a physiologically relevant context22,23,24,25,26.
Here we show that administration of an LH analogue in vivo or EGF in vitro triggers a loss of the TZPs that occurs uniformly 4–8 h later. TZP loss is not due to displacement of cumulus cells away from the oocyte, but rather to an active and highly synchronized retraction of these processes into the cumulus cell bodies. Unexpectedly, and in contrast to the process of elaboration, TZP retraction is not regulated by oocyte-derived signals, but is instead controlled exclusively by signaling within the granulosa cells. TZP retraction depends on ERK-dependent activation in these cells of calpain, which triggers loss of adhesion between the TZPs and the oocyte, and on the actin-assembly nucleator complex, Arp2/3, whose activity is required for the TZPs to shorten. We further show that granulosa cells do not acquire the ability to undergo TZP retraction until the antral stage of folliculogenesis, indicating that it is developmentally regulated. Our results uncover mechanistic elements of the process that frees the germ cell from control by its somatic microenvironment at the time of ovulation, enabling it to participate in fertilization.
Activation of EGFR signalling induces retraction of TZPs
To uncover the mechanism responsible for TZP loss, we first established its timing. We injected female mice with the FSH analogue, equine chorionic gonadotropin (eCG), to promote the final stage of follicular development, followed by the LH analogue, human chorionic gonadotropin (hCG), to induce maturation. At different times following hCG injection, we isolated cumulus-oocyte complexes (COCs) from antral follicles, fixed them, and stained them using phalloidin, a bicyclic peptide originally isolated from Amanita phalloides that binds to filamentous (F-) actin, to label TZPs and DAPI to label DNA.
Prior to the initiation of maturation, a dense network of TZPs links the granulosa cells to the immature oocyte, whose chromatin is dispersed within the nucleus, termed the germinal vesicle (GV) (Fig. 2a, 0 h, arrow indicates TZPs). By 4 h post-hCG, the maturing oocytes had undergone germinal vesicle breakdown (GVBD) although the condensed chromosomes had not yet become aligned on the first meiotic spindle (Fig. 2a, 4 h, inset). At this time, the TZP network remained intact (Fig. 2a; Fig. 2b, 100.0 ± 0.25% [mean ± standard error of the mean] n = 12), consistent with reports that gap junctional communication between the two cell types persists for a short period of time after GVBD10,27. Strikingly, however, by 8 h post-hCG virtually no TZPs could be detected (Fig. 2a, 8 h; Fig. 2b, 0.03 ± 0.007%, n = 11). These results indicate, first, that TZPs are lost approximately midway through maturation and, second, that the loss occurs several hours after the maturing oocyte has undergone GVBD. Because the subset of follicles that have responded to the FSH activity by expressing LH-receptors is challenging to reliably identify in intact ovaries, it was not feasible to use in vivo approaches to further dissect the timing and mechanism of TZP loss. We therefore turned to an established in vitro model whereby COCs are isolated from large antral follicles of eCG-primed mice and allowed to mature in vitro21.
The cumulus granulosa cells, which elaborate the TZPs, express EGFR but not LHCGR19,28,29. This suggested to us that TZP loss might be mediated through an EGFR-regulated pathway. To test whether EGFR signaling drives the loss of TZPs during maturation, we incubated COCs in the presence of EGF (Fig. 2c, d). After 4 h of incubation, the oocytes had undergone GVBD and contained condensed chromosomes, as observed during maturation in vivo. At this time, 87.4 ± 9.5% (n = 34) of the starting population of TZPs remained. By 8 h, many of the oocytes had completed the first meiotic division, as indicated by the presence of the first polar body (arrow in Fig. 2c, EGF 8 h). Importantly, only 8.6 ± 6.1% (n = 39) of the TZPs remained, closely matching the results observed in vivo. In contrast, COCs incubated for 8 h in the absence of EGF retained 74.2 ± 15.3% (n = 55) of the initial TZP population. To verify that EGF-triggered TZP loss through activation of its receptor, we incubated EGF-treated complexes in the presence of either of two inhibitors of EGFR signaling, PD153035 and AG1478, previously used on mouse ovarian follicles in vitro30. Both effectively suppressed the EGF-triggered loss of TZPs (Supplementary Fig. 1a). A small decrease in TZP number occurred even in the presence of the EGFR inhibitors, and we address this EGFR-independent decrease later in this report. These results show that activation of EGFR signaling in COCs in vitro triggers loss of the TZPs and that the timing of this process recapitulates that observed in vivo.
Because phalloidin stains F-actin, the presence or absence of staining could not establish whether the membranous structure of the TZP, as well as its actin backbone, was lost. To meet this concern, we evaluated two markers associated with the plasma membrane. We stained COCs obtained from wild-type mice using anti-β-catenin, and COCs obtained from (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo) that express a membrane-targeted Tomato Red using anti-RFP (red fluorescent protein). Because of the weak fluorescent signal obtained using anti-RFP, we removed the bodies of the granulosa cells prior to fixation, leaving the TZPs embedded within the zona pellucida. Prior to maturation, both markers revealed the dense TZP network also observed using phalloidin (Fig. 2e). In contrast, 8 h after exposure to EGF, very few TZPs were detectable using either membrane marker. These observations establish that, both in vivo and in vitro, the TZPs are synchronously lost 4–8 h following the initiation of maturation.
The loss of TZPs could be an active process—due to retraction of the filopodial structure—or passive—due to the displacement of the cumulus cells away from the oocyte during maturation (see Fig. 1). Careful examination of COCs between 4 and 8 h following administration of hCG (in vivo) or EGF (in vitro) revealed that the layers of cumulus granulosa cells nearest to the oocyte had not become displaced, but instead remained adjacent to the zona pellucida (Fig. 2f). Short projections often extended from these cells into the zona pellucida. When multiple projections extended from a single locus at the cell surface, the bases of these projections typically were clustered, forming a bouquet-like structure (Fig. 2f, arrowheads). These observations indicate that, following EGF stimulation, the TZPs shorten in concert with a reorganization of the cortical actin network of the cumulus granulosa cells. We observed the same loss of TZPs when we allowed porcine COCs to undergo maturation in vitro, where the multiple layers of cumulus cells remain closely adjacent to the oocyte (Supplementary Fig. 1b). These results definitively establish that the loss of TZPs from the cumulus cells adjacent to the oocyte during maturation is due to an active process of retraction.
Cyclic GMP stabilizes TZPs in COCs
Previous reports have shown that, when COCs are incubated in vitro in the absence of EGFR ligands, the oocytes mature and the TZPs are lost11,18. To understand the relationship between these observations and our results, we incubated COCs for an extended period of time in the absence of EGF (Fig. 3a, b). Consistent with the previous reports, the oocytes within the COCs underwent maturation, as indicated by the presence of condensed chromosomes at 4 h and 8 h (arrows in Fig. 3a) and of the first polar body at 12 h and 16 h. After 8 h of incubation, 70.7 ± 14.8% (n = 54) of the original population of TZPs remained, indicating that a modest decline had occurred by this time. After 16 h of incubation, however, only 2.6 ± 1.9% (n = 16) remained. These results indicate that TZPs are lost in vitro even in the absence of EGF, but the timing is considerably delayed compared to in its presence. EGFR signaling requires its dimerization, and this can occur in the absence of ligand-binding31, raising the possibility that EGFR in cumulus cells might exhibit a weak ligand-independent activity eventually leading to TZP retraction. In contrast to the EGF-triggered loss of TZPs, however, the slow loss of TZPs in the absence of EGF was not attenuated by the chemical inhibitors of EGFR signaling (Supplementary Fig. 1c). These results indicate that, although EGFR signaling is required to recapitulate the physiological timing and synchrony of TZP retraction observed in vivo, an EFGR-independent mechanism can drive a slow process of retraction in vitro.
Fully grown oocytes within antral follicles are held in meiotic arrest through the action of cyclic GMP (cGMP)19. cGMP is produced by the membrane guanylyl cyclase natriuretic peptide receptor 2 (NPR2) upon activation by its ligand, C-type natriuretic peptide (CNP) (Fig. 3c). Whereas NPR2 is present on both mural and cumulus granulosa cells, CNP is secreted only by the mural granulosa cells32. Consequently, COCs once removed from the antral follicle and placed in culture become deprived of CNP. This leads to a drop in cGMP in both the cumulus granulosa cells and the oocyte, enabling the latter to initiate meiotic maturation. We wondered whether the drop in cGMP might underlie the slow EGFR-independent TZP loss.
To test this, we incubated COCs in the presence of CNP, which has previously been shown to elevate cGMP within COCs and block maturation32,33,34 or 8-pCPT-cGMP, a membrane-permeable analogue of cGMP35. Oocytes incubated for 18 h in the presence of either CNP or 8-pCPT-cGMP remained in meiotic arrest, as indicated by the presence of the GV (dashed circles in Fig. 3d), confirming that intracellular cGMP remained elevated. Moreover, the population of TZPs remained remarkably stable (98.2 ± 13.2%, n = 34 for CNP; 98.9 ± 9.0%, n = 28 for 8-pCPT-cGMP) (Fig. 3d, e). The ability of CNP to prevent TZP loss has previously been reported12,36,37, and our results using 8-pCPT-cGMP provide evidence that as anticipated this effect is mediated through elevated intracellular cGMP.
LH triggers a rapid drop in cGMP concentration in both the cumulus cells and the oocyte via multiple mechanisms including increased activity of the cGMP-specific phosphodiesterase (PDE) 5A38 and decreased activity of NPR239,40, and this drop is detectable within minutes after exposing intact antral follicles to LH in vitro41. Because TZP retraction does not occur until between 4 and 8 h later, the drop in cGMP is unlikely to directly drive TZP retraction in vivo. Nevertheless, we wished to learn whether elevated cGMP could impair the EGF-mediated retraction. To test this, we incubated COCs for 8 h in the presence of EGF and either CNP or 8-pCPT-cGMP (Fig. 3f, g). Whereas 26.7 ± 8.4% (n = 20) of the TZPs remained in the presence of EGF alone, 80.2 ± 20.3% (n = 43) remained when 8-pCPT-cGMP was also present. CNP was less efficient at blocking retraction, as 45.7 ± 14.9% (n = 25) of the TZPs remained after 8 h. We also noted that more than half of the oocytes underwent GVBD under this latter condition, which suggests that cGMP levels declined. The reduced ability of CNP to prevent TZP retraction (and maturation) in the presence of EGF, as compared to in its absence (compare Fig. 3e, g), may reflect the fact that EGFR signaling decreases the activity of NPR242. These results suggest that the LH-triggered decrease in cGMP concentration within the cumulus cells may facilitate efficient EGFR-mediated TZP retraction.
TZP retraction occurs independently of oocyte maturation
TZP retraction does not begin until several hours after maturing oocytes have undergone germinal vesicle breakdown (GVBD) and entered metaphase of the cell cycle. Intriguingly, cytoskeletal elements of the oocyte cortical region become extensively modified early during maturation43,44. We observed that prior to maturation, E-cadherin is distributed in small foci that are present around the circumference of the oocyte, likely reflecting its localization at the points of membrane contact with the TZPs (Fig. 4a) and consistent with reports implicating cadherins in maintaining adhesion between the granulosa cells and oocyte45,46. Following GVBD, however, membrane-associated E-cadherin is no longer detectable, although it reappears at the surface of oocytes that have completed maturation to metaphase II (ref. 47). β-catenin becomes similarly depleted from the oocyte surface following GVBD (Fig. 4a). The loss of surface E-cadherin together with the relative timing of GVBD and TZP retraction suggested that changes in the oocyte membrane during maturation might uncouple adhesion with the TZPs, leading to their retraction.
Oocyte maturation begins when the decrease in cGMP relieves inhibition of phosphodiesterase (PDE) 3A within the ooplasm, enabling it to hydrolyze cyclic AMP thereby permitting activation of cyclin-dependent kinase (CDK) 119,30,48(Fig. 4b). To test whether changes in the oocyte during maturation underpin TZP retraction, we exposed EGF-treated COCs either to cilostamide, a PDE3A inhibitor that maintains elevated intracellular cAMP, or to roscovitine, which acts downstream by blocking CDK1 activity (Fig. 4b). Both inhibitors effectively blocked maturation, as indicated by the presence of the GV, and inhibited the depletion of cortical E-cadherin (Fig. 4c). Despite the meiotic arrest, however, only 11.0 ± 6.0% (n = 52) of the TZPs remained in the COCs exposed to cilostamide, compared to 10.3 ± 4.6% (n = 27) in the control (Fig. 4d, e). Roscovitine modestly suppressed TZP retraction, such that 27.0 ± 22.8% (n = 36) remained of the population present prior to treatment. As roscovitine inhibits the maturation pathway downstream of cilostamide, the partial suppression of retraction may reflect a non-specific action of the drug. These results demonstrate that TZP retraction is not driven by a mechanism that is activated downstream of the decrease in oocyte cAMP.
To further test whether oocyte maturation controls TZP retraction, we incubated COCs in the presence of CNP while blocking gap junctional activity. This experimental condition generates high levels of cGMP in the granulosa cells, yet low levels in the oocyte. Under this condition, the oocytes underwent maturation, as expected because cGMP transfer from the granulosa cells had been blocked (Fig. 4f, CNP + CBX, note polar body). Remarkably, however, 93.1 ± 14.0% (n = 25) of the TZPs remained (Fig. 4f, g). These results establish that although TZP retraction and oocyte maturation are temporally linked, they are mechanistically independent. Rather, TZP retraction is regulated primarily or exclusively by mechanisms operating within the granulosa cells.
TZP retraction requires ERK activity
We next sought to identify these mechanisms. A key mediator of EGFR signalling in many cell types, including the granulosa cells, is the ERK-MAP kinase (hereafter termed ERK) pathway33,49,50. To test whether the ERK pathway mediates EGFR-induced TZP loss, we co-cultured COCs with EGF and U0126, a highly selective inhibitor that has been widely used to block this pathway in oocytes and granulosa cells51,52. Consistent with previous reports, oocytes underwent GVBD but failed to complete the first meiotic division in the presence of U0126 (Fig. 5a, inset). Strikingly, 94.6 ± 19.5% (n = 28) of the TZPs remained, indicating that inhibiting ERK activity completely blocked TZP retraction (Fig. 5a, b).
In view of the normal morphology of the TZPs, we then tested whether they retained functional properties. We treated COCs as above and, at the end of the 8-h culture period, injected Lucifer Yellow, a fluorescent dye that can pass through gap junctions, into the oocyte15,53. Following a 30-minute incubation to allow dye-transfer, we imaged the COCs. In COCs cultured in EGF alone, no fluorescence was observed in the cumulus cells, indicating that gap junctions no longer connected them to the oocyte (Fig. 5c). In contrast, extensive dye-transfer to the cumulus granulosa cells occurred in COCs cultured in EGF and U0126, indicating that functional gap junctions remained. These results demonstrate that the oocyte and cumulus granulosa cells remain in contact and communication, even in the presence of EGF, when ERK signaling is blocked and provide a mechanistic basis for previous observations that in vivo genetic or in vitro pharmacological inhibition of ERK activity in granulosa cells at the time of ovulation prevents the loss of germ-soma gap junctional communication49,54.
TZP retraction requires activity of calpain and Arp2/3
We then searched for potential targets of ERK signaling. The calpains are ERK-activated cysteine proteases whose targets include proteins implicated in cell adhesion and whose activation is associated with a loss of actin-based cell protrusions55,56. Calpain 2 is expressed in granulosa cells, but not in oocytes, and calpain activity slowly increases during maturation, peaking at 8 h post-hCG57. Moreover, calpain is activated in COCs in vitro by EGFR ligands, and its activation is blocked both by U0126 and by a commonly used small-molecule inhibitor, calpain inhibitor I (CI-I)57. To test whether activation of calpain was required for TZP retraction, we exposed EGF-treated COCs to CI-I. Consistent with the previous report57 and confirming the activity of the drug, we observed that expansion of the cumulus layer was impaired. Quantification of the number of TZPs revealed that 56.2 ± 25.0% (n = 38) remained in COCs exposed to EGF and CI-I, as compared to only 12.7 ± 12.5% (n = 30) in COCs exposed to EGF alone (Fig. 6a, b). These TZPs were closely apposed to the oocyte surface and morphologically indistinguishable from those of COCs not treated with EGF. Inhibiting calpain activity thus blocks TZP retraction at an early stage.
The observation that TZPs remained closely apposed to the oocyte surface in the presence of calpain suggested that it may regulate adhesion between the TZPs and the oocyte. Previous studies suggest that adhesion may depend on interaction between N-cadherin and E-cadherin on the surface of the TZPs and oocyte, respectively45,46. We found that N-cadherin is present at points of contact between the TZPs and oocyte (Fig. 6c, arrow, asterisks). Notably, in some cases, we detected N-cadherin along the shaft of the TZP (Fig. 6c, arrowhead), confirming its granulosa cell origin. We also detected tight junction protein-1 (TJP1, also known as ZO-1), a component of the protein complex that couples cadherins to actin58, at the TZP-oocyte interface (Supplementary Fig. 2a; see also ref. 45). To test whether TZP-oocyte adhesion depends on adherens junctions, which are calcium-dependent, we incubated COCs in Ca-free medium for 15 min and then fixed them. We found that this treatment provoked a widespread detachment of the TZPs from the oocyte surface (Fig. 6d). Although depletion, albeit brief, of external calcium may affect other cellular components, these results support the interpretation that adherens junctions are required to maintain adhesion between the TZPs and the oocytes.
This result suggests that calpain-dependent disruption of adherens junctions may be an early step in TZP retraction. To evaluate this possibility, we treated COCs with EGF in the presence or absence of calpain inhibitor and counted the number of N-cadherin foci, which represent the sites of TZP-oocyte contact, at the oocyte surface under these conditions (Fig. 6e, f). Prior to EGF treatment, we observed 58.2 ± 28.4 (n = 22) foci of N-cadherin at the oocyte surface. Eight hr after EGF treatment, however, only 8.4 ± 4.3 (n = 25) foci were detectable. This result is consistent with the widespread retraction of TZPs that occurs under these conditions. In sharp contrast, 27.8 ± 12.7 (n = 32) foci remained in COCs treated in the presence of the calpain inhibitor. It is noteworthy that the inhibitor exerted a quantitatively similar effect on the number of TZPs and the number of N-cadherin foci (compare Fig. 6b, f). Thus, experimental conditions that inhibit TZP retraction also inhibit the loss of N-cadherin from the TZP tips. Further supporting a link between calpain activity and loss of cell-surface N-cadherin, we observed punctae of N-cadherin staining between cumulus cells prior to EGF treatment and, to a lesser extent, in COCs treated with EGF and the calpain inhibitor (Supplementary Fig. 2b, arrows). In contrast, in the COCs treated with EGF alone, N-cadherin was more uniformly distributed in the cortical regions and could also be detected within the cytoplasm from surface of the cumulus cells (Supplementary Fig. 2b, arrowheads). These results support a model in which activation of EGFR signaling leads to a calpain-dependent loss of N-cadherin from TZP tips, thereby physically uncoupling the TZPs from the oocyte.
To pursue the mechanisms that drive TZP retraction following detachment from the oocyte, we focused on the F-actin backbone, as this must be disassembled or otherwise modified for retraction to occur. Actin monomers are assembled into F-actin by nucleator proteins. Proteins of the formin family generate linear filaments; conversely, the Arp2/3 complex generates branched chains by nucleating new filaments that grow out at an angle from existing filaments. Although the relative roles of Arp2/3 and formins in generating filopodia remains to be fully elucidated (reviewed in59), inhibitors of formin and Arp2/3 can reduce and increase, respectively, the number of filopodia60. Moreover, the formin, DAAM1, is present in TZPs15, implying that their growth may be supported by the assembly of linear filaments. Because Arp2/3 may oppose filopodial growth under certain conditions, as noted above, and can be activated through ERK signaling43,61, we reasoned that activation of Arp2/3 might mediate TZP retraction.
To test this idea, we treated COCs with EGF for 8 h in the absence or presence of the canonical inhibitor of Arp2/3-mediated actin assembly, CK666, which acts by stabilizing the inactive form of the complex62 and has previously been used to inhibit Arp2/3 in oocytes43,63. We found that the TZPs detached from the oocyte under these conditions, as indicated by the visible gap between the tips of the TZPs and the oocyte surface marked by phalloidin staining (Fig. 6g). Strikingly, however, although some TZPs had also become shorter, many continued to span most of the width of the zona (Fig. 6g). When we quantified this data, we found that, whereas 0.02 ± 0.04% of the TZPs (n = 28) remained in the COCs treated with EGF alone, 51.6 ± 19.3% (n = 12) and 70.4 ± 18.0% (n = 45) remained in COCs also exposed to CK666 at concentrations of 50 μM and 200 μM, respectively (Fig. 6h). These results identify two phases of TZP retraction—an Arp2/3-independent detachment from the oocyte surface, which does not require Arp2/3 activity, followed by an Arp2/3-dependent shortening of the TZP.
Finally, we determined at what stage of folliculogenesis granulosa cells acquire the ability to initiate TZP retraction. We collected granulosa-cell oocyte complexes (GOCs) from late pre-antral follicles and cultured them overnight with EGF. Because EGFR expression in pre-antral follicles may be insufficient to respond to its ligands64 we also tested VEGF and PDGF, which also activate the ERK pathway in target cells, and together with their receptors are expressed in granulosa cells65,66. Each growth factor increased phosphorylation of ERK in the granulosa cells, indicating that receptor signaling had been activated (Supplementary Fig. 2c). Despite this, none of the growth factors triggered TZP retraction even after overnight culture (Fig. 6i). We conclude that the ability to initiate TZP retraction is acquired by granulosa cells at the pre-antral to antral transition during folliculogenesis.
Loss of adhesion to the somatic cells that support and direct germ-cell differentiation is essential to germ-cell function. In mammalian females, this occurs through a loss of the specialized filopodia known as TZPs that couple cumulus granulosa cells to the oocyte. Here, we have defined the timing of TZP loss and uncovered components of the mechanism that drives this process. TZPs undergo retraction between 4 and 8 h after the ovulatory process is initiated in antral follicles by injection of hCG, which binds to LHCGR. In contrast to the elaboration of the TZPs, which occurs over a period of 2-3 weeks in the mouse15 and likely several months in humans, their loss is highly synchronized and occurs within a period of only a few hours. This indicates that the activating signal is generated at the same time throughout the cumulus granulosa cell population or is rapidly propagated among cells. Retraction is also triggered by treating COCs obtained from antral follicles with EGF in vitro, suggesting that, in vivo, LHCGR signaling triggers retraction via its well-established activation of EGFR signaling. In addition, whereas the oocyte plays a key role in TZP elaboration, by sending inductive signals to the granulosa cells, it plays little or no role in TZP loss.
Our results suggest a model for TZP retraction comprising three principal events (Fig. 7). First, activation of EGFR leads to phosphorylation and activation of ERK-MAP kinase49. Activation of ERK increases calpain activity in cumulus cells57. We propose that, second, this increase disrupts complexes between N-cadherin on the cumulus cell surface and E-cadherin on the oocyte surface, thereby physically uncoupling the two cell types. Activation of ERK can also increase the activity of the Arp2/3 complex43,61. We propose that, third, Arp2/3 activation changes the cellular environment from one favouring linear F-actin to one favouring branched F-actin. This causes the linear F-actin filaments of the TZPs shorten owing to continuing pointed-end disassembly67, leading ultimately to resorption of the TZPs into the body of the cumulus cells.
Our results identify several questions to be addressed in future studies. First, the molecular target of calpain is not yet known. N-cadherin, which is a known substrate of calpain56, is a potential candidate. Our immunofluorescence results indicate, however, that although membrane-associated N-cadherin foci are lost in a calpain-dependent manner during retraction, the protein remains present in the cytoplasm. This suggests that N-cadherin is not extensively degraded within the time-period of our experiments, although does not exclude a quantitatively minor degradation that is functionally important. Intracellular proteins that interact with the cadherins to regulate the stability of adherens junctions are also potential targets; these include β-catenin, which has been identified as a calpain target56, as well as α- and p120-catenin, and TJP1, which can bind to actin thereby linking it to cadherins. Alternatively, tight-junction or other complexes may mediate TZP-oocyte adhesion and could be targets for calpain-dependent cleavage; however, these have not been detected at this interface45. Second, the mechanism by which EGFR-ERK signaling increases Arp2/3 activity remains to be identified. Arp2/3 is activated by members of the WASP (Wiscott-Aldrich syndrome protein) or WAVE (WASP-family verprolin-homologous protein) families, which by binding to the complex induce a conformational change68,69. Thus, it is possible that increased expression or availability of a WASP/WAVE family member triggers an increase in Arp2/3 activity.
Although EGFR signaling drives TZP retraction within the physiological time-frame, TZPs also retract slowly when COCs are removed from the follicle and incubated in the absence of EGFR ligands. This retraction is prevented by agents that raise intracellular cGMP, suggesting that cGMP inhibits an EGFR-independent mechanism of retraction. Although the role of cGMP in regulating oocyte maturation by inhibiting PDE3A in the oocyte is well defined19, other roles for the cGMP produced by the granulosa cells had not previously been described. The ability of cGMP to inhibit TZP retraction may be relevant to our observation that EGF was unable to induce TZP retraction in pre-antral follicles, even though ERK became phosphorylated indicating activation of receptor signaling. One explanation for this result is that the concentration of cGMP in pre-antral follicles is high and remains so when the GOC is removed from the follicle. Alternatively, pre-antral granulosa cells may lack the machinery to initiate retraction in response to activated ERK. Regardless of the mechanism, the acquisition of the ability to undergo TZP retraction only at the antral stage of folliculogenesis serves to ensure that coupling between the oocyte and its somatic environment is not prematurely terminated. By defining mechanisms that control the developmentally regulated maintenance and disruption of germ-soma communication, our results may help to refine methods to achieve germ cell development in vitro, both to better understand the molecular basis of cellular totipotency and to preserve fertility in rare species and in women24,70,71.
All experiments were performed in compliance with the regulations and policies of the Canadian Council on Animal Care and were approved by the Animal Care Committee of the Research Institute of the McGill University Health Centre (RI-MUHC; permit #7783). CD-1 mice were obtained from Charles River (St-Constant, QC). mTmG (membrane-Tomato/membrane-Green) founder mice were obtained (Jackson Laboratory, Bar Harbor, ME; strain 007676) and a colony established at the RI-MUHC. These mice carry a transgene encoding a membrane-targeted fluorescent protein. Targeting is mediated via the first 8 amino acids of the plasma membrane associated protein, MARCKS. Mice were housed at 21 °C with 40–60% relative humidity under a 12 h/12 h light/dark regime. Swine ovaries were obtained from prepubertal gilts collected from a local abattoir (Olymel, Saint Esprit, Quebec, Canada).
Collection and culture of cells
Murine COCs containing fully grown oocytes and GOCs containing growing oocytes were collected from post-natal day (PD) 19–21 mice that had received an intraperitoneal injection of 5 IU of equine chorionic gonadotropin (Sigma, Windsor, ON) 44 hr previously (referred to as eCG-primed) and PD 17 mice, respectively, as described22,23. COCs were collected in Hepes-buffered minimal essential medium (MEM-H) containing cilostamide to prevent meiotic resumption. To permit meiotic resumption, COCs were incubated in cilostamide-free bicarbonate-buffered MEM at 37o in an atmosphere of 5% CO2 in air. Depending on the experiment, the following supplements were added to the indicated final concentration: EGF (10 ng/ml, BD Biosciences 354052), AG1478 (500 nM, Calbiochem 658552) PD153035 (5 µM Calbiochem 234490), CNP (100 nM, Sigma N8768), 8-pCPT-cGMP (2.5 mM, Sigma C5438), carbenoxolone (150 µM, Sigma C4790), cilostamide (15 µM, Sigma C7971), roscovitine (10 µM, Sigma R7772), U0126 (25 µM, Sigma U120), CI-I (5 µM, Sigma A6185), CK-666 (50 or 200 µM, Sigma SML0006). For experiments involving CI-I and CK666, cilostamide was also added to the culture medium to prevent GVBD so that EGF-triggered retraction could be studied independently of oocyte maturation. GOCs were incubated in the presence or absence of EGF, VEGF (150 ng/mL, R&D 220-BB-010), or PDGF (50 ng/mL, R&D 293-VE-010).
Porcine COCs were collected from 3 to 6 mm follicles and those having at least three layers of cumulus cells and homogeneous cytoplasm were selected for maturation. Ovaries of prepubertal gilts were obtained from a local abattoir (Olymel S.E.C./L.P., Saint-Esprit, QC) and transported to the laboratory in 0.9% NaCl at 32 °C to 35 °C. Follicles ranging from 3 to 6 mm in diameter were aspirated using an 18-gauge needle. Only cumulus-oocyte complexes (COCs) surrounded by a minimum of three cumulus cell layers and having an evenly granulated cytoplasm were selected for IVM. To permit maturation, groups of 30 COCs were incubated at 38.5 °C in a humidified atmosphere of 5% CO2 in air 0.1 ml drops of medium under mineral oil. Initial incubation was in TCM 199 (Life Technologies, Burlington, ON) supplemented with 20% porcine follicular fluid, 1 mM dibutyryl cyclic adenosine monophosphate (dbcAMP), 0.1 mg/ml cysteine, 10 ng/ml epidermal growth factor (Life Technologies), 0.91 mM sodium pyruvate, 3.05 mM D-glucose, 0.5 μg/ml luteinizing hormone (LH; Sioux Biochemical, Inc., Sioux Center, IA), 0.5 μg/ml follicle-stimulating hormone (FSH; Sioux Biochemical), and 20 μg/ml gentamicin (Life Technologies). After 22–24 h of incubation, COCs were transferred to the same medium lacking LH, FSH, and dbcAMP and incubated for an additional 20–22 h.
COCs, GOCs, and denuded oocytes were fixed for 15 min in freshly prepared 2% (w/v) para-formaldehyde (Fisher Scientific 04042) in phosphate-buffered saline (PBS, pH 7.2) containing 0.1% Triton X-100 (PBST; ACROS 9002-93-1), then washed in PBST. The specimens were incubated overnight in primary antibody in PBST at 4 °C with gentle agitation, washed twice in PBST, then incubated for 1 hr at room temperature in the secondary antibody as well as phalloidin and DAPI in PBST, then washed in PBST. To mount the samples, a 9 × 0.12 mm spacer (GBL654008, Sigma) was attached to a glass microscope slide. A 2 µl drop of PBS containing 0.3% Polyvinylpyrrolidone (Sigma, PVP360) was placed in the center of the spacer and covered with 20 µl of mineral oil. Samples were then transferred into the drop of PBS and a cover slip was placed on top. Samples were imaged using a LSM 880 confocal microscope (Zeiss, Toronto, ON). The following reagents were used for fluorescent detection of specific proteins: Phalloidin-TRITC (1:100, P1951, Sigma), Phalloidin-Alexa 488 (1:100, A12379, Thermo Fisher), DAPI (1:100, Roche 10236276001), anti-E-cadherin (1:100, BD Transduction Laboratories, 610181), anti-β-catenin (1:100, BD Transduction Laboratories, 610153), anti-RFP (1: 400, Cedarlane, 600-401-379), anti-N-cadherin (1:100, Abcam 18203), anti-TJP1 (1:100, Novus NBP1-85047), anti-rabbit IgG-Alexa 488 (1:100, Thermo Fisher, A11008), anti-mouse IgG-Alexa 488 (1:100, Thermo Fisher, A11001). Tyramide SuperBoost™ Kit with Alexa Fluor™ Tyramide (Invitrogen) was used to amplify the β-catenin signal, following the manufacturer’s directions.
Granulosa cells were collected and lysed in 10 μl of Laemmli buffer. After denaturation, proteins were separated using pre-cast 12% gels (456-8045, Bio Rad) and transferred onto a polyvinylidene fluoride membrane (Amersham, Oakville, ON, Canada) under constant voltage. The membrane was subsequently blocked using 5% non-fat milk, in 0.1% Tween-PBS. The membrane was washed three times in Tween-PBS and incubated with primary antibody overnight at 4 °C. After washing, the membrane was incubated in secondary antibody conjugated to horseradish peroxidase (Promega) at a dilution of 1:5000 for 1 h at room temperature. After the final washes, bound antibody was revealed using ECL+ n(Amersham). Antibodies used were against phospho-p44/42 ERK (1:1000, Cell Signalling 9106) and TACC3 (1:1000, Abcam 134154).
Confocal image analysis
To quantify the number of actin-TZPs, a confocal optical section was obtained at the equatorial plane of the oocyte. Using Fiji software (National Institutes of Health, Bethesda, MD), a segmented circle was created around the oocyte circumference, in the middle of the zona pellucida, and the fluorescence intensity at each point on the line was determined. Each point whose value was above the background value of the oocyte cytoplasm and higher than each of its immediately neighboring points was counted as a TZP. The algorithm used to perform this calculation is provided in the Source File. The total number of TZPs counted by this method, although not representing the total number of TZPs in the specimen, was considered as the TZP number associated with the oocyte. For each experiment, except as below, specimens were collected, imaged, and analyzed for each treatment group, and the results were normalized to the mean value obtained for the control group. When the time-course of TZP loss in the absence of EGF was assessed, it was not possible to collect all treatment groups for each experiment.
To quantify the number of N-cad foci, images of the COCs were captured at a z-plane where the oocyte diameter was 50 μm, as the signal at the equator was weak owing to the presence of the cumulus cells. Using ImageJ, the oocyte cortex was traced using Freehand selections tool, and the number of foci of fluorescence above a threshold set at maximal intensity in oocyte cytoplasm were counted in this area. This value was divided by the size area to enable different specimens to be compared.
Analysis of gap junctional coupling
The oocyte of each COC was injected with about 10 pl of a 100 mM solution of Lucifer Yellow (Thermo Fisher L12926), using a Zeiss Axio Observer Z1 microscope and PLI-100 microinjector (Medical Systems, NY). The complexes were incubated for 30 min to allow dye transfer to the cumulus granulosa cells and then examined using fluorescence microscopy.
Statistics and reproducibility
Data were collected from a minimum of three biological replicates for each experimental series. No technical replicates were included in the data or n-value used for statistical analyses and no data was eliminated from the analyses. Quantitative data were analyzed using GraphPad Prism (9.0.0) employing one-way ANOVA and the Tukey multiple-comparison tests, as described in the figure legends. The confocal images displayed in each figure were obtained from the same experiments that were used to obtain the quantitative data.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Data related to the findings of this study as well as the algorithm used to calculate the relative number of TZPs are provided as a source file. Additional information and materials are available from the corresponding author upon request. Source data are provided with this paper.
Gumbiner, B. M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84, 345–357 (1996).
Paolillo M., Schinelli S. Extracellular matrix alterations in metastatic processes. Int. J. Mol. Sci. 20, 4947 (2019).
Gungor-Ordueri, N. E., Tang, E. I., Celik-Ozenci, C. & Cheng, C. Y. Ezrin is an actin binding protein that regulates Sertoli cell and spermatid adhesion during spermatogenesis. Endocrinology 155, 3981–3995 (2014).
Sakamoto, S. et al. mDia1/3 generate cortical F-actin meshwork in Sertoli cells that is continuous with contractile F-actin bundles and indispensable for spermatogenesis and male fertility. PLoS Biol. 16, e2004874 (2018).
Hannigan, M. M., Zagore, L. L. & Licatalosi, D. D. Ptbp2 controls an alternative splicing network required for cell communication during spermatogenesis. Cell Rep. 19, 2598–2612 (2017).
Clarke H. J. Regulation of germ cell development by intercellular signaling in the mammalian ovarian follicle. Wiley Interdiscip Rev Dev Biol 7, https://doi.org/10.1002/wdev.1294 (2018).
Sánchez, F. & Smitz, J. Molecular control of oogenesis. Biochim. Biophys. Acta 1822, 1896–1912 (2012).
Conti, M. & Franciosi, F. Acquisition of oocyte competence to develop as an embryo: integrated nuclear and cytoplasmic events. Hum. Reprod. Update 24, 245–266 (2018).
Guo, J. et al. Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice. Proc. Natl Acad. Sci. USA 115, E5326–e5333 (2018).
Chen, J. et al. Somatic cells regulate maternal mRNA translation and developmental competence of mouse oocytes. Nat. Cell Biol. 15, 1415–1423 (2013).
Yuan, Y. et al. Quadrupling efficiency in production of genetically modified pigs through improved oocyte maturation. Proc. Natl Acad. Sci. USA 114, E5796–E5804 (2017).
Sanchez, F. et al. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield. Hum. Reprod. 32, 2056–2068 (2017).
Li, R. & Albertini, D. F. The road to maturation: somatic cell interaction and self-organization of the mammalian oocyte. Nat. Rev. Mol. Cell Biol. 14, 141–152 (2013).
Wassarman, P. M. & Litscher, E. S. Biogenesis of the mouse egg’s extracellular coat, the zona pellucida. Curr. Top. Dev. Biol. 102, 243–266 (2013).
El-Hayek, S., Yang, Q., Abbassi, L., FitzHarris, G. & Clarke, H. J. Mammalian oocytes locally remodel follicular architecture to provide the foundation for germline-soma communication. Curr. Biol. 28, 1124–1131 (2018).
Baena, V. & Terasaki, M. Three-dimensional organization of transzonal projections and other cytoplasmic extensions in the mouse ovarian follicle. Sci. Rep. 9, 1262 (2019).
Macaulay, A. D. et al. Cumulus cell transcripts transit to the bovine oocyte in preparation for maturation. Biol. Reprod. 94, 16 (2016).
Macaulay, A. D. et al. The gametic synapse: RNA transfer to the bovine oocyte. Biol. Reprod. 91, 90 (2014).
Jaffe, L. A. & Egbert, J. R. Regulation of mammalian oocyte meiosis by intercellular communication within the ovarian follicle. Annu. Rev. Physiol. 79, 237–260 (2016).
Conti, M., Hsieh, M., Musa Zamah, A. & Oh, J. S. Novel signaling mechanisms in the ovary during oocyte maturation and ovulation. Mol. Cell Endocrinol. 356, 65–73 (2012).
Richani, D. & Gilchrist, R. B. The epidermal growth factor network: role in oocyte growth, maturation and developmental competence. Hum. Reprod. Update 24, 1–14 (2018).
El-Hayek, S., Yang, Q. & Clarke, H. J. Growth in vitro of granulosa cell-oocyte complexes of the mouse. Methods Mol. Biol. 1818, 1–11 (2018).
O’Brien, M. J., Pendola, J. K. & Eppig, J. J. A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol. Reprod. 68, 1682–1686 (2003).
Gargus, E. S., Rogers, H. B., McKinnon, K. E., Edmonds, M. E. & Woodruff, T. K. Engineered reproductive tissues. Nat. Biomed. Eng. 4, 381–393 (2020).
Smitz, J. et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum. Reprod. Update 16, 395–414 (2010).
Telfer, E. E. & Zelinski, M. B. Ovarian follicle culture: advances and challenges for human and nonhuman primates. Fertil. Steril. 99, 1523–1533 (2013).
Eppig, J. J. The relationship between cumulus cell-oocyte coupling, oocyte meiotic maturation, and cumulus expansion. Dev. Biol. 89, 268–272 (1982).
Park, J.-Y. et al. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 303, 682–684 (2004).
Eppig, J. J., Wigglesworth, K., Pendola, F. & Hirao, Y. Murine oocytes suppress expression of luteinizing hormone receptor messenger ribonucleic acid by granulosa cells. Biol. Reprod. 56, 976–984 (1997).
Vaccari, S., Weeks, J. L. II, Hsieh, M., Menniti, F. S. & Conti, M. Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes. Biol. Reprod. 81, 595–604 (2009).
Byrne, P. O., Hristova, K. & Leahy, D. J. EGFR forms ligand-independent oligomers that are distinct from the active state. J. Biol. Chem. 295, 13353–13362 (2020).
Zhang, M., Su, Y. Q., Sugiura, K., Xia, G. & Eppig, J. J. Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science 330, 366–369 (2010).
Wang, Y. et al. Epidermal growth factor receptor signaling-dependent calcium elevation in cumulus cells is required for NPR2 inhibition and meiotic resumption in mouse oocytes. Endocrinology 154, 3401–3409 (2013).
Richard, S. & Baltz, J. M. Prophase I arrest of mouse oocytes mediated by natriuretic peptide precursor C requires GJA1 (connexin-43) and GJA4 (connexin-37) gap junctions in the antral follicle and cumulus-oocyte complex. Biol. Reprod. 90, 137 (2014).
Blaha, M., Nemcova, L. & Prochazka, R. Cyclic guanosine monophosphate does not inhibit gonadotropin-induced activation of mitogen-activated protein kinase 3/1 in pig cumulus-oocyte complexes. Reprod. Biol. Endocrinol. 13, 1 (2015).
Santiquet, N. W. et al. A pre-in vitro maturation medium containing cumulus oocyte complex ligand-receptor signaling molecules maintains meiotic arrest, supports the cumulus oocyte complex and improves oocyte developmental competence. Mol. Hum. Reprod. 23, 594–606 (2017).
Romero, S., Sanchez, F., Lolicato, F., Van Ranst, H. & Smitz, J. Immature oocytes from unprimed juvenile mice become a valuable source for embryo production when using C-type natriuretic peptide as essential component of culture medium. Biol. Reprod. 95, 64 (2016).
Egbert, J. R. et al. Luteinizing hormone causes phosphorylation and activation of the cGMP phosphodiesterase PDE5 in rat ovarian follicles, contributing, together with PDE1 activity, to the resumption of meiosis. Biol. Reprod. 94, 110 (2016).
Robinson, J. W. et al. Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes. Dev. Biol. 366, 308–316 (2012).
Egbert, J. R. et al. Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes. Development 141, 3594–3604 (2014).
Shuhaibar, L. C. et al. Intercellular signaling via cyclic GMP diffusion through gap junctions restarts meiosis in mouse ovarian follicles. Proc. Natl Acad. Sci. USA 112, 5527–5532 (2015).
Hao, X. et al. Epidermal growth factor-mobilized intracellular calcium of cumulus cells decreases natriuretic peptide receptor 2 affinity for natriuretic peptide type C and induces oocyte meiotic resumption in the mouse. Biol. Reprod. 95, 45 (2016).
Chaigne, A. et al. A soft cortex is essential for asymmetric spindle positioning in mouse oocytes. Nat. Cell Biol. 15, 958–966 (2013).
Larson, S. M. et al. Cortical mechanics and meiosis II completion in mammalian oocytes are mediated by myosin-II and Ezrin-Radixin-Moesin (ERM) proteins. Mol. Biol. Cell 21, 3182–3192 (2010).
Mora, J. M. et al. Characterization and significance of adhesion and junction-related proteins in mouse ovarian follicles. Biol. Reprod. 86, 153 (2012).
Wang, C. & Roy, S. K. Expression of E-cadherin and N-cadherin in perinatal hamster ovary: possible involvement in primordial follicle formation and regulation by follicle-stimulating hormone. Endocrinology 151, 2319–2330 (2010).
Takezawa, Y. et al. Beta-catenin is a molecular switch that regulates transition of cell-cell adhesion to fusion. Sci. Rep. 1, 68 (2011).
Norris, R. P. et al. Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. Development 136, 1869–1878 (2009).
Fan, H. Y. et al. MAPK3/1 (ERK1/2) in ovarian granulosa cells are essential for female fertility. Science 324, 938–941 (2009).
Yang, C. R., Lowther, K. M., Lalioti, M. D. & Seli, E. Embryonic poly(A)-binding protein (EPAB) is required for granulosa cell EGF signaling and cumulus expansion in female mice. Endocrinology 157, 405–416 (2016).
Sha, Q. Q. et al. A MAPK cascade couples maternal mRNA translation and degradation to meiotic cell cycle progression in mouse oocytes. Development 144, 452–463 (2017).
Verlhac, M. H., de Pennart, H., Maro, B., Cobb, M. H. & Clarke, H. J. MAP kinase becomes stably activated at metaphase and is associated with microtubule-organizing centers during meiotic maturation of mouse oocytes. Dev. Biol. 158, 330–340 (1993).
Veitch, G. I., Gittens, J. E., Shao, Q., Laird, D. W. & Kidder, G. M. Selective assembly of connexin37 into heterocellular gap junctions at the oocyte/granulosa cell interface. J. Cell Sci. 117, 2699–2707 (2004).
Sela-Abramovich, S., Edry, I., Galiani, D., Nevo, N. & Dekel, N. Disruption of gap junctional communication within the ovarian follicle induces oocyte maturation. Endocrinology 147, 2280–2286 (2006).
Kerstein, P. C., Patel, K. M. & Gomez, T. M. Calpain-mediated proteolysis of talin and FAK regulates adhesion dynamics necessary for axon guidance. J. Neurosci. 37, 1568–1580 (2017).
Franco, S. J. & Huttenlocher, A. Regulating cell migration: calpains make the cut. J. Cell Sci. 118, 3829–3838 (2005).
Kawashima, I. et al. EGF-like factors induce expansion of the cumulus cell-oocyte complexes by activating calpain-mediated cell movement. Endocrinology 153, 3949–3959 (2012).
Zaidel-Bar, R. Cadherin adhesome at a glance. J. Cell Sci. 126, 373–378 (2013).
Gallop, J. L. Filopodia and their links with membrane traffic and cell adhesion. Semin Cell Dev. Biol. 102, 81–89 (2020).
Pfisterer, K. et al. FMNL2 regulates dynamics of fascin in filopodia. J. Cell Biol. 219, e201906111 (2020).
Mendoza, M. C., Vilela, M., Juarez, J. E., Blenis, J. & Danuser, G. ERK reinforces actin polymerization to power persistent edge protrusion during motility. Sci. Signal 8, ra47 (2015).
Chanez-Paredes, S., Montoya-Garcia, A. & Schnoor, M. Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds. Cell Mol. Life Sci. 76, 3349–3361 (2019).
Wang, H. et al. Symmetry breaking in hydrodynamic forces drives meiotic spindle rotation in mammalian oocytes. Sci. Adv. 6, eaaz5004 (2020).
El-Hayek, S., Demeestere, I. & Clarke, H. J. Follicle-stimulating hormone regulates expression and activity of epidermal growth factor receptor in the murine ovarian follicle. Proc. Natl Acad. Sci. USA 111, 16778–16783 (2014).
Rico, C. et al. HIF1 activity in granulosa cells is required for FSH-regulated VEGFA expression and follicle survival in mice. Biol. Reprod. 90, 135 (2014).
Sleer, L. S. & Taylor, C. C. Cell-type localization of platelet-derived growth factors and receptors in the postnatal rat ovary and follicle. Biol. Reprod. 76, 379–390 (2007).
Carlier, M. F. et al. Control of polarized assembly of actin filaments in cell motility. Cell Mol. Life Sci. 72, 3051–3067 (2015).
Molinie, N. & Gautreau, A. The Arp2/3 regulatory system and its deregulation in cancer. Physiol. Rev. 98, 215–238 (2018).
Swaney, K. F. & Li, R. Function and regulation of the Arp2/3 complex during cell migration in diverse environments. Curr. Opin. Cell Biol. 42, 63–72 (2016).
Hikabe, O. et al. Reconstitution in vitro of the entire cycle of the mouse female germ line. Nature 539, 299–303 (2016).
Jones, A. S. K. & Shikanov, A. Follicle development as an orchestrated signaling network in a 3D organoid. J. Biol. Eng. 13, 2 (2019).
This work was supported by grants from the Canadian Institutes of Health Research (CIHR; PJT 153122), and the Natural Sciences and Engineering Research Council of Canada (RGPIN-402138) to H.J.C. We gratefully acknowledge the generous fellowship support provided by the following agencies: Faculty of Medicine, McGill University (L.A.), McGill Centre for Research in Reproduction and Development (L.A.), CIHR Training Program in Reproduction, Early Development, and the Impact on Health (S.E.H.), Réseau Québécois en Reproduction (S.E.H., S.G.A.), Research Institute of the McGill University Health Centre (S.E.H.), Samuel Solomon Endocrinology Fellowship (K.F.C.), and the China Scholarship Council (W.W.). We thank Shibo Feng and Min Fu (RI-MUHC Imaging Platform) for their invaluable assistance and our colleagues for advice and discussion.
The authors declare no competing interests.
Peer review information Nature Communications thanks Laurinda Jaffe and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Abbassi, L., El-Hayek, S., Carvalho, K.F. et al. Epidermal growth factor receptor signaling uncouples germ cells from the somatic follicular compartment at ovulation. Nat Commun 12, 1438 (2021). https://doi.org/10.1038/s41467-021-21644-z